Meloxicam
- Product NDC
- 70934-297
- 11-digit product format
- 709340297
- Labeler code
- 70934
- Product ID
- 70934-297_a5654132-ca5e-f592-e053-2a95a90a69eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meloxicam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA077918
- Marketing category
- ANDA
- Marketing start
- 2019-02-26
- Marketing end
- 0000-00-00
- Substance
- MELOXICAM
- Active strength
- 8 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-297-30 | 70934029730 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-297-30) | 30 tablet | 2019-02-26 | 0000-00-00 | No | No | Current |
| 70934-297-60 | 70934029760 | 60 TABLET in 1 BOTTLE, PLASTIC (70934-297-60) | 60 tablet | 2019-03-25 | 0000-00-00 | No | No | Current |
| 70934-297-90 | 70934029790 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-297-90) | 90 tablet | 2020-04-28 | 0000-00-00 | No | No | Current |